- Home
- LGND
as 04-24-2025 4:00pm EST
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 2.0B | IPO Year: | 1992 |
| Target Price: | $144.67 | AVG Volume (30 days): | 116.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $69.17 - $129.90 | Next Earning Date: | 05-08-2025 |
| Revenue: | $167,133,000 | Revenue Growth: | 27.28% |
| Revenue Growth (this year): | 16.47% | Revenue Growth (next year): | 19.44% |
Latest Ligand Pharmaceuticals Incorporated News
LGND Breaking Stock News: Dive into LGND Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 hours ago
Ligand to Report First Quarter 2025 Financial Results on May 8, 2025
Zacks Small Cap Research
2 days ago
LGND: Pelthos To Become Public Company
Argus Research
2 days ago
LGND: What does Argus have to say about LGND?
MT Newswires
7 days ago
Sector Update: Health Care Stocks Softer Thursday Afternoon
MT Newswires
7 days ago
Update: Ligand Pharmaceuticals to Merge Units With Channel Therapeutics to Launch Pelthos Therapeutics
MT Newswires
7 days ago
Top Midday Gainers
MT Newswires
7 days ago
Ligand Pharmaceuticals to Merge Units With Channel Therapeutics to Launch Pelthos Therapeutics
GlobeNewswire
7 days ago
Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics
Compare LGND vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LGND Ligand Pharmaceuticals Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.